This is a Validated Antibody Database (VAD) review about Rhesus mon.. CD84, based on 6 published articles (read how Labome selects the articles), using CD84 antibody in all methods. It is aimed to help Labome visitors find the most suited CD84 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CD84 synonym: SLAM family member 5
BioLegend
mouse monoclonal (CD84.1.21) |
| In order to detail MAIT cell responses to various microorganisms and cytokines, BioLegend CD84 antibody (BioLegend, CD84.1.21) was used in flow cytometry on human samples (fig 6a). Proc Natl Acad Sci U S A (2017) ncbi |
mouse monoclonal (CD84.1.21) |
| In order to investigate the role of long-lived plasma cells in immunity and autoimmunity, BioLegend CD84 antibody (BioLegend, CD84.1.21) was used in flow cytometry on human samples (fig 1a). J Immunol (2017) ncbi |
mouse monoclonal (CD84.1.21) |
| In order to investigate the function of SLAMF in phagocytosis of haematopoietic tumour cells, BioLegend CD84 antibody (Biolegend, CD84.1.21) was used in flow cytometry on mouse samples (fig e3a) and in flow cytometry on human samples (fig e6b). Nature (2017) ncbi |
mouse monoclonal (CD84.1.21) |
| In order to characterize activated T cells in joint tissue from patients with rheumatoid arthritis, BioLegend CD84 antibody (biolegend, CD84.1.21) was used in flow cytometry on human samples . Nature (2017) ncbi |
mouse monoclonal (CD84.1.21) |
| In order to study the effect of anti-SLAMF6 antibody and ibrutinib on chronic lymphocytic leukemia cells, BioLegend CD84 antibody (biolegend, CD84.1.21) was used in flow cytometry on human samples (fig 1d). Oncotarget (2016) ncbi |
mouse monoclonal (CD84.1.21) |
| In order to find cell-surface markers specific to human neutrophils, BioLegend CD84 antibody (Biolegen d, 326008) was used in flow cytometry on human samples (fig st1). Exp Cell Res (2016) ncbi |
Articles Reviewed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments